| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.41 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |